中国癌症杂志 ›› 2015, Vol. 25 ›› Issue (7): 555-560.doi: 10.3969/j.issn.1007-3969.2015.07.011

• 论著 • 上一篇    

Luminal B型乳腺癌的治疗及其靶点的研究进展

孙运坡 综述 应学翔,何萍青 审校   

  1. 上海交通大学附属第六人民医院普外科,上海 200233
  • 出版日期:2015-07-30 发布日期:2015-12-09
  • 通信作者: 何萍青 E-mail:hpq0916@aliyun.com

Research progress of treatment and therapeutic target for Luminal B breast cancer

SUN Yunpo, YING Xuexiang, HE Pingqing   

  1. Department of General Surgery, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai 200233,China
  • Published:2015-07-30 Online:2015-12-09
  • Contact: HE Pingqing E-mail: hpq0916@aliyun.com

摘要: 根据基因表达谱的不同,乳腺癌被分成4种不同的亚型:基底样型、人类表皮生长因子受体2(HER-2)过表达型、Luminal A型和Luminal B型。尽管Luminal型乳腺癌存在相似之处,但研究发现Luminal A型和Luminal B型乳腺癌是两种不同的实体。Luminal B型乳腺癌激素受体低表达,该类型乳腺癌预后相对较差,对化疗及内分泌治疗的反应不同。该文回顾了Luminal B型乳腺癌对化疗及内分泌治疗不同反应的临床依据,以及目前正在研究的新的治疗靶点。

关键词: 乳腺癌, Luminal B型, 治疗, 靶点

Abstract: Breast cancer can be classified into 4 intrinsic subtypes by gene expression profiling: basal-like, HER-2-positive, Luminal A and Luminal B. Although Luminal cancers share similarities, the studies showed that Luminal A and B breast cancers should be perceived as distinct entities. Luminal B breast cancer has lower expression of hormone receptors, and it also exhibits worse prognosis and has a distinct profile of response to chemotherapy and endocrine therapy. This review presented the available clinical evidence for chemotherapy and endocrine therapy patterns of response, and potential targets for treatment.

Key words: Breast cancer, Luminal B subtype, Treatment, Target